At a glance
- Depends onUpstream position: supplies 3 industries, depends on 0
- ScaleMarket cap is $10.32M, lower than 95% of all stocks globally
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2024 (year ended December 31, 2024). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
7.64MGBP10.32M · vs all stocks (USD)
Revenue (TTM)
11.79MGBP15.92M · vs all stocks (USD)
Profit Margin
-14.82%Beta
0.2690xvs all stocks
52-Week Change
-26.32%vs all stocks
Market Capitalization
7.64MGBP10.32M · vs all stocks (USD)
Enterprise Value
5.54MGBP7.49M · vs all stocks (USD)
Price to Sales (TTM)
0.6481xPrice to Book (MRQ)
1.16xvs Shell Companies peers
Enterprise to Revenue
0.4700xEnterprise to EBITDA
-4.58xvs Shell Companies peers
Profit Margin
-14.82%Operating Margin
-15.66%Return on Assets (TTM)
-9.92%vs Shell Companies peers
Return on Equity (TTM)
-49.57%Revenue (TTM)
11.79MGBP15.92M · vs all stocks (USD)
Revenue per Share (TTM)
0.1020GBPUpdated Jul 29, 2026Quarterly Revenue Growth
167.30%Gross Profit (TTM)
2.97MGBP4.01M · vs all stocks (USD)
EBITDA (TTM)
-1.21MGBP-1.64M · vs all stocks (USD)
Net Income (TTM)
-1.75MGBP-2.36M · vs all stocks (USD)
Operating Cash Flow (TTM)
-2.31MGBP-3.12M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.45MGBP-1.96M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00GBPUpdated Jul 29, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
2.64MGBPFY2024 · Dec 31, 2024Cost of Goods Sold
2.29MGBPFY2024 · Dec 31, 2024Gross Profit
348.00KGBPFY2024 · Dec 31, 2024Operating Income
-1.16MGBP-1.56M · vs all stocks (USD)
Pre-tax Income
-2.88MGBPFY2024 · Dec 31, 2024Income Tax Expense
-195.00KGBPFY2024 · Dec 31, 2024Net Income
-2.82MGBPFY2024 · Dec 31, 2024EBIT
-2.82MGBPFY2024 · Dec 31, 2024EBITDA (Income Statement)
-1.05MGBPFY2024 · Dec 31, 2024Selling, General & Administrative
700.00KGBPFY2024 · Dec 31, 2024Other Operating Expenses
148.00KGBPFY2024 · Dec 31, 2024Non-operating Interest Income
39.00KGBPFY2024 · Dec 31, 2024Non-operating Interest Expense
61.00KGBPFY2024 · Dec 31, 2024EPS (Basic)
-0.0005GBPFY2024 · Dec 31, 2024EPS (Diluted)
-0.0005GBPFY2024 · Dec 31, 2024Basic Shares Outstanding
61.39MSharesFY2024 · Dec 31, 2024Diluted Shares Outstanding
61.39MSharesFY2024 · Dec 31, 2024Preferred Stock Dividends
0.00GBPFY2024 · Dec 31, 2024Operating Cash Flow
-2.85MGBPFY2024 · Dec 31, 2024Free Cash Flow
-2.92MGBPFY2024 · Dec 31, 2024Cash & Cash Equivalents (End of Period)
1.97MGBPFY2024 · Dec 31, 2024Starting Profit (CF Statement)
-2.88MGBPFY2024 · Dec 31, 2024Stock-based Compensation
23.00KGBPFY2024 · Dec 31, 2024Other Non-cash Items
-166.00KGBPFY2024 · Dec 31, 2024Change in Accounts Receivable (CF)
162.00KGBPFY2024 · Dec 31, 2024Change in Other Assets/Liabilities
8.00KGBPFY2024 · Dec 31, 2024Capital Expenditures
-63.00KGBPFY2024 · Dec 31, 2024Net Acquisitions
-747.00KGBPFY2024 · Dec 31, 2024Net Investing Cash Flow
-810.00KGBPFY2024 · Dec 31, 2024Long-term Debt Issuance
0.00GBPFY2024 · Dec 31, 2024Long-term Debt Payments
-89.00KGBPFY2024 · Dec 31, 2024Other Financing Charges
480.00KGBPFY2024 · Dec 31, 2024Net Financing Cash Flow
6.05MGBPFY2024 · Dec 31, 2024Shares Outstanding
133.91MSharesUpdated Jul 29, 2026Float Shares
47.19MSharesUpdated Jul 29, 2026% Held by Insiders
34.83%vs all stocks
% Held by Institutions
51.11%vs all stocks
Total Cash (MRQ)
1.08MGBP1.45M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0080GBPUpdated Jul 29, 2026Total Debt (MRQ)
2.27MGBP3.06M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6045xvs Shell Companies peers
Current Ratio (MRQ)
1.01xvs Shell Companies peers
Book Value per Share (MRQ)
0.0280GBPUpdated Jul 29, 2026Total Assets
8.94MGBP12.07M · vs all stocks (USD)
Total Current Assets
3.70MGBPFY2024 · Dec 31, 2024Total Liabilities
4.96MGBPFY2024 · Dec 31, 2024Total Non-current Assets
5.24MGBPFY2024 · Dec 31, 2024Total Non-current Liabilities
1.57MGBPFY2024 · Dec 31, 2024Total Current Liabilities
3.39MGBPFY2024 · Dec 31, 2024Cash
1.38MGBPFY2024 · Dec 31, 2024Cash & Cash Equivalents
1.38MGBPFY2024 · Dec 31, 2024Accounts Receivable
1.13MGBPFY2024 · Dec 31, 2024Inventory
145.00KGBPFY2024 · Dec 31, 2024Accounts Payable
1.22MGBPFY2024 · Dec 31, 2024Short-term Debt
1.20MGBPFY2024 · Dec 31, 2024Other Current Liabilities
180.00KGBPFY2024 · Dec 31, 2024Long-term Debt
414.00KGBPFY2024 · Dec 31, 2024Other Non-current Liabilities
1.16MGBPFY2024 · Dec 31, 2024Common Stock (Book)
4.09MGBPFY2024 · Dec 31, 2024Retained Earnings
-15.77MGBPFY2024 · Dec 31, 2024Total Shareholders' Equity
3.98MGBP5.37M · vs all stocks (USD)
52-Week Low
3.00GBXUpdated Jul 29, 202652-Week High
6.85GBXUpdated Jul 29, 202652-Week Change
-26.32%vs all stocks
Beta
0.2690xvs all stocks
50-Day MA
3.72GBXUpdated Jul 29, 2026200-Day MA
4.63GBXUpdated Jul 29, 2026Avg 10-Day Volume
637.68KSharesUpdated Jul 29, 2026Avg 30-Day Volume
343.73KSharesUpdated Jul 29, 2026Diluted EPS (TTM)
-0.0200GBPUpdated Jul 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Upstream position: supplies 3 industries, depends on 0Notable
Outgoing: 3.00Incoming: 0.00
Scale
Market cap is $10.32M, lower than 95% of all stocks globallySignificant
Market cap (USD): 10,315,453.886Global P5: 269,387,740.27
Revenue is $15.92M, lower than 95% of all stocks globallySignificant
Revenue (USD): 15,915,996.05Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Bay Capital Plc
Tier 1RiskApproval-Gated PipelineInterfaceFlow
GigCapital7 Corp.
Tier 1RiskApproval-Gated PipelineInterfaceFlow
Translational Development Acquisition Corp.
Tier 1RiskApproval-Gated PipelineInterfaceFlow
Legato Merger Corp III
Tier 1RiskApproval-Gated PipelineInterfaceFlow
1RT Acquisition Corp.
Tier 1RiskApproval-Gated PipelineInterfaceFlow
Dynamix Corporation
Tier 1RiskApproval-Gated PipelineInterfaceFlow
Plum Acquisition Corp IV
Tier 1RiskApproval-Gated PipelineInterfaceFlow
Drugs Made In America Acquisition Corp.
Tier 1RiskApproval-Gated PipelineInterfaceFlow
ION Acquisition Corp 3 Ltd.
Tier 1RiskApproval-Gated PipelineFlowInterface
FinTech Evolution Acquisition Group
Tier 1RiskApproval-Gated PipelineInterfaceFlow